{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:30:04Z","timestamp":1794555004906,"version":"4.9.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T00:00:00Z","timestamp":1621123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Vasculitis Foundation USA"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["K2013-52X-20307-07-3"],"award-info":[{"award-number":["K2013-52X-20307-07-3"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2018-02551"],"award-info":[{"award-number":["2018-02551"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"King Gustaf V\u2019s 80-Year Fund"},{"name":"Swedish Rheumatism Association and Ume\u00e5 University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Pulmonary manifestations in RA are common comorbidities. Interstitial lung disease (ILD), both idiopathic and in RA, has been associated with several genetic variants. We assessed pulmonary fibrosis (PF) in an inception cohort of RA patients in relation to genetic variants and disease-related factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 1466 early RA patients were consecutively included and followed prospectively from the index date until death or 31 December 2016. Clinical and laboratory data and treatment were continuously registered according to the Swedish Rheumatology Quality Register. DNA was available from 1184 patients and 571 151 genome-wide single-nucleotide polymorphisms (SNPs) were analysed. Thirteen identified genetic variants were extracted. At follow-up, the patients answered a questionnaire regarding disease progression and lung involvement that was validated by reviewing medical records and analysing radiological examinations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The prevalence of PF was 5.6% and the annualized incidence rate was 5.0\/1000 (95% CI 3.80, 6.54). Four SNPs were associated with PF in RA: rs35705950 [MUC5B; OR 2.5 (95% CI 1.5, 4.0), adjusted P-value\u2009=\u20090.00016, q-value\u2009=\u20090.0021]; rs111521887 [TOLLIP; OR 1.9 (95% CI 1.3, 2.8), adjusted P-value\u2009=\u20090.0014, q-value\u2009=\u20090.0092]; rs2609255 [FAM13A; OR 1.7 (95% CI 1.1, 2.5), adjusted P-value\u2009=\u20090.013, q-value\u2009=\u20090.055] and rs2736100 [TERT; OR 1.5 (95% CI 1.0, 2.2), adjusted P-value\u2009=\u20090.046, q-value\u2009=\u20090.15]. Older age and RF positivity were associated with increased risk, while MTX treatment was associated with a lower risk of PF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Development of PF in an inception cohort of RA patients was associated with 4 of 12 ILD risk genes. RA-related factors except for age at diagnosis and RF positivity were of limited importance in PF development.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab441","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T11:09:35Z","timestamp":1620990575000},"page":"943-952","source":"Crossref","is-referenced-by-count":35,"title":["Pulmonary fibrosis in relation to genetic loci in an inception cohort of patients with early rheumatoid arthritis from northern Sweden"],"prefix":"10.1093","volume":"61","author":[{"given":"Elias","family":"J\u00f6nsson","sequence":"first","affiliation":[{"name":"Department of Public Health and Medicine\/Rheumatology, Ume\u00e5 University, Ume\u00e5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8999-0925","authenticated-orcid":false,"given":"Lotta","family":"Ljung","sequence":"additional","affiliation":[{"name":"Department of Public Health and Medicine\/Rheumatology, Ume\u00e5 University, Ume\u00e5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Norrman","sequence":"additional","affiliation":[{"name":"Department of Public Health and Medicine\/Rheumatology, Ume\u00e5 University, Ume\u00e5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0226-1047","authenticated-orcid":false,"given":"Eva","family":"Freyhult","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3965-9403","authenticated-orcid":false,"given":"Lisbeth","family":"\u00c4rlestig","sequence":"additional","affiliation":[{"name":"Department of Public Health and Medicine\/Rheumatology, Ume\u00e5 University, Ume\u00e5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6283-644X","authenticated-orcid":false,"given":"Johanna","family":"Dahlqvist","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry and Microbiology, and Medical Sciences, Uppsala, University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-3863","authenticated-orcid":false,"given":"Solbritt","family":"Rantap\u00e4\u00e4-Dahlqvist","sequence":"additional","affiliation":[{"name":"Department of Public Health and Medicine\/Rheumatology, Ume\u00e5 University, Ume\u00e5"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,5,16]]},"reference":[{"key":"2022030208031256600_keab441-B1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years","volume":"62","author":"Turesson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2022030208031256600_keab441-B2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/ard.56.10.596","article-title":"Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis","volume":"56","author":"Cortet Perez","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"2022030208031256600_keab441-B3","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","article-title":"A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","volume":"76","author":"Hyldgaard","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022030208031256600_keab441-B4","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/annrheumdis-2015-208216","article-title":"Signs of immune activation and local inflammation are present in the bronchial tissue of patients with untreated early rheumatoid arthritis","volume":"75","author":"Reynisdottir","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022030208031256600_keab441-B5","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2014a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2022030208031256600_keab441-B6","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Jr. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"key":"2022030208031256600_keab441-B7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/resp.12234","article-title":"Predictors of mortality in rheumatoid arthritis-related interstitial lung disease","volume":"19","author":"Assayag","year":"2014","journal-title":"Respirology"},{"key":"2022030208031256600_keab441-B8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur Respir J"},{"key":"2022030208031256600_keab441-B9","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1164\/rccm.200408-1104OC","article-title":"Clinical and pathologic features of familial interstitial pneumonia","volume":"172","author":"Steele","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2022030208031256600_keab441-B10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1164\/rccm.201905-1017OC","article-title":"Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis","volume":"201","author":"Allen","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2022030208031256600_keab441-B11","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201903-0511OC","article-title":"Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis","volume":"200","author":"Hobbs","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2022030208031256600_keab441-B12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng.2609","article-title":"Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis","volume":"45","author":"Fingerlin","year":"2013","journal-title":"Nat Genet"},{"key":"2022030208031256600_keab441-B13","doi-asserted-by":"crossref","first-page":"e1901","DOI":"10.1097\/MD.0000000000001901","article-title":"Association between the MUC5B promoter polymorphism rs35705950 and idiopathic pulmonary fibrosis: a meta-analysis and trial sequential analysis in Caucasian and Asian populations","volume":"94","author":"Zhu","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"2022030208031256600_keab441-B14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S2213-2600(13)70045-6","article-title":"Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study","volume":"1","author":"Noth","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2022030208031256600_keab441-B15","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Kuduri","year":"2010","journal-title":". Rheumatology (Oxford)"},{"key":"2022030208031256600_keab441-B16","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"2022030208031256600_keab441-B17","doi-asserted-by":"crossref","first-page":"1602314","DOI":"10.1183\/13993003.02314-2016","article-title":"Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis","volume":"49","author":"Juge","year":"2017","journal-title":"Eur Respir J"},{"key":"2022030208031256600_keab441-B18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2022030208031256600_keab441-B19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/BOR.0000000000000380","article-title":"Recent advances in the pathogenesis, prediction, and management of rheumatoid arthritis-associated interstitial lung disease","volume":"29","author":"Johnson","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"2022030208031256600_keab441-B20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41584-019-0275-x","article-title":"Mechanisms of lung disease development in rheumatoid arthritis","volume":"15","author":"Wang","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2022030208031256600_keab441-B21","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2022030208031256600_keab441-B22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2022030208031256600_keab441-B23"},{"key":"2022030208031256600_keab441-B24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2022030208031256600_keab441-B25","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar2214","article-title":"The PTPN221858C\/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden","volume":"9","author":"Kokkonen","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"2022030208031256600_keab441-B26","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2022030208031256600_keab441-B27"},{"key":"2022030208031256600_keab441-B28","doi-asserted-by":"crossref","first-page":"e64683","DOI":"10.1371\/journal.pone.0064683","article-title":"Imputing amino acid polymorphisms in human leukocyte antigens","volume":"8","author":"Jia","year":"2013","journal-title":"PLoS One"},{"key":"2022030208031256600_keab441-B29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1463-1326.2008.00997.x","article-title":"Overview of the MHC fine mapping data","volume":"11(Suppl 1","author":"Brown","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"2022030208031256600_keab441-B30","year":"2018"},{"key":"2022030208031256600_keab441-B31","doi-asserted-by":"crossref","first-page":"e028466","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"key":"2022030208031256600_keab441-B32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2022030208031256600_keab441-B33","first-page":"564","article-title":"Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease","volume":"34","author":"Sebastiani","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2022030208031256600_keab441-B34","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-015-3025-8","article-title":"Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis","volume":"34","author":"Restrepo","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2022030208031256600_keab441-B35","first-page":"1","article-title":"Anti-cyclic citrullinated peptide antibodies and severity of interstitial lung disease in women with rheumatoid arthritis","volume":"2015","author":"Rocha-Mu\u00f1oz","year":"2015","journal-title":"J Immunol Res"},{"key":"2022030208031256600_keab441-B36","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/rheumatology\/kez337","article-title":"Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature","volume":"58","author":"Fragoulis","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2022030208031256600_keab441-B37","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/rheumatology\/keaa327","article-title":"Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study","volume":"60","author":"Ibfelt","year":"2021","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab441\/38865673\/keab441.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/3\/943\/42671953\/keab441.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/3\/943\/42671953\/keab441.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T08:05:36Z","timestamp":1646208336000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/3\/943\/6276448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,16]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,5,16]]},"published-print":{"date-parts":[[2022,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab441","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,5,16]]}}}